Back to search
FDAFDA · Food and drugs·Recall number D-0530-2023

Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India NDC 31722-713-10

Published April 19, 2023 · Recall initiated: March 14, 2023

Summary

FDA records drug Class II recall D-0530-2023, published April 19, 2023 and initiated March 14, 2023. Recalling firm: Hetero USA Inc; Status: Ongoing; Reported quantity: 2,352 bottles; Lot: Lot #: PAN22542, Exp. Date: 9/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Discoloration

What to do

Letter

Get an email if PANTOPRAZOLE SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PANTOPRAZOLE SODIUM
Manufacturer
Hetero USA Inc
Distributor
Nationwide within the United States
UPC
0331722713900
Lot
Lot #: PAN22542, Exp. Date: 9/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals Inc., Piscataway, NJ, 08854, By: Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahabubnagar- 509 301, India NDC 31722-713-10 recalled?

Yes. FDA published recall D-0530-2023 on April 19, 2023. Reported hazard: CGMP Deviations: Discoloration

What should I do if I have this product?

Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PANTOPRAZOLE SODIUM. UPC: 0331722713900.